In recent years, more emphasis is being placed on increasing racial diversity in clinical trials. Research indicates that subject enrollment in clinical trials does not match the population that is most likely to suffer from the disease. Often times, sites lack effective plans for increasing diversity in subject enrollment. Research also shows that racial minorities are less aware of clinical trials and often have negative perceptions of clinical trials.

Download this article to learn more about:

• • Efforts at Rho to increase racial diversity in clinical trials
    • The role of the CRA in addressing racial diversity
    • Racial Equity Impact Assessment
    • Case Study